Nepean Hospital

Penrith, New South Wales 2751

2 studies enrolling now · 8 studies all time

What they study most

Catecholamine-resistant Hypotension (CRH), Critical Illness, Deep Venous Thrombosis, Distributive Shock, High Output Shock, Lung Cancer, NASH - Nonalcoholic Steatohepatitis, Non-Small Cell Lung Cancer (NSCLC), Non-small Cell Lung Cancer (NSCLC), Primary Sclerosing Cholangitis, Sepsis, Type 2 Diabetes Mellitus

Studies at this site

• A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201) — Recruiting now
• A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) — Recruiting now
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Running, not enrolling
• Study of Cilofexor in Adults With Primary Sclerosing Cholangitis — Stopped early
• A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension — Completed
• Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer — Completed
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT) — Completed